Comparison of genetic changes in transitional and squamous bilharzial-related bladder cancers using flourescence in situ hybridization

International Journal of Cancer Research

Volumn 3, Issue 2, 2007, Pages 127-133

  Al Qahtani, Ahmed A ^a   Aly, Magdy S ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Bladder cancer; Genetics; In situ hybridization; Schistosoma; Squamous cell carcinoma; Transitional cell carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CARCINOGENESIS; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC CORRELATION; GENETIC DIFFERENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

EID: 34249309205     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2007.127.133     Document Type: Article

References (29)

1. Aly, M.S. and H.M. Khaled, 1999. Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization. Cancer Genet. Cytogenet, 114: 62-67.
2. Aly, M.S. and H.M. Khaled, 2002. Chromosomal aberrations in early-stage bilharzial bladder cancer. Cancer Genet. Cytogenet, 132: 41-45.
3. Aly, M.S. and H.M. Khaled, 2004. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridizaton. Urol. Oncol., 22: 448-452.
4. Chaudhary, K.S., Q. Lu, P.D. Abel, N. Khandan-Nia, A.M. Shorna, M. El Baz, G.W. Stamp and E.N. Lalani, 1997. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder. Br. J. Urol., 79: 78-84.
5. Dean, A.L., F.K. Mostofi, R.V. Thomson and M.L. Clark, 1954. A restudy of the first fourteen hundred tumors in the Bladder Tumor Registry of the Armed Forces Institute of Pathology. J. Urol., 71: 571-590.
6. El-Bolkainy, M.N., M.A. Ghoneim and M.A. Mansour, 1972. Carcinoma of the bilharzial bladder in Egypt: Clinical and pathological features. Br. J. Urol., 44: 561-570.
7. El-Bolkainy, M.N., N.M. Mokhtar, M.A. Ghoneim and M.H. Hussein, 1981. The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer, 48: 2643-2648.
8. El-Rifai, W., D. Kamel, M.L. Larramendy, S. Shoman, Y. Gad S. Baithun, M. El-Awady, S. Eissa, H. Khaled, S. Soloneski, M. Sheaff and S. Knuutila, 2000. DNA copy number changes in schistosoma-associated and non-schistosoma-associated bladder cancer. Am. J. Pathol., 156: 871-878.
9. Ghaleb, A.H., J.G. Pizzolo and M.R. Melamed, 1996. Aberrations of chromosomes 9 and 17 in bilharzial bladder cancer as detected by fluorescence in situ hybridization. Am. J. Clin. Pathol., 106: 234-241.
10. Gibas, Z. and L. Gibas, 1997. Cytogenetics of bladder cancer. Cancer Genet. Cytogenet, 95: 108-115.
11. Gonzalez-Zulueta, M., A. Shibata, P.F. Ohneseit, C.H. Spruck, C. Busch, M. Shamaa, M. El-Baz, P.W. Nichols, M.L. Gonzalgo and M. Elbaz et al., 1995. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J. Natl. Cancer Inst., 87: 1383-1393.
12. Kamel, D., Y. Soini, K. Nuorva, A. Khalifa, A. Mangoud, K. Vahakangas and P. Paakko, 1994. P53 and c-crbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions. Virchows Arch., 424: 349-355.
13. Khaled, H.M., M.S. Aly and N. Mokhtar, 2004. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: A theory of pathogenesis. Urol. Oncol., 22: 443-447.
14. Mostofi, F.K., L.H. Sobin and H. Torloni, 1973. Histological typing of urinary bladder tumors. International Histological Classification of Tumours, World Health Organizatior, Geneva, Switzerland.
15. Mostofi, F.K., C.J. Davis Jr and I.A. Sesterhenn, 1988. Pathology of Tumors of the Urinary Tract. In: Skinner, D.G. and G. Lieskovsky (Eds.), Diagnosis and Management of Genitourinary Cancer. Saunders, Philadelphia, PA, pp: 83-117.
16. Olumi, A.F., E.C. Skinner, Y.C. Tsai and P.A. Jones, 1990. Molecular analysis of human bladder cancer. Semin Urol., 8: 270-277.
17. Osman, I., H. I. Scher, Z. F. Zhang, I. Pellicer, R. Hamza, S. Eissa, H. Khaled and C. Cordon-Cardo, 1997. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer. Clin. Cancer Res., 3: 531-536.
18. Ozakyol, A., M. Ozdemir and S. Artan, 2006. Fish detected p53 deletion and N-MYC amplification in colorectal cancer. Hepatogastroenterology, 53: 192-195.
19. Pycha, A., C. Mian, A. Haitel, J. Hofbauer, H. Wiener, M. Marberger, 1997. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer. J. Urol., 157: 2116-2119.
20. Sandberg, A.A. and C.S. Berger, 1994. Review of chromosome studies in urological tumors. 11. Cytogenetics and molecular genetics of bladder cancer. J. Urol., 151: 545-560.
21. Sidransky, D., A. Von Eschenbach, Y.C. Tsai, P. Jones, I. Summerhayes, F. Marshall, M. Paul, P. Green, S.R. Hamilton and P. Frost et al., 1991. Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252: 706-709.
22. Spruck, C.H., P.F. Ohnescit, M. Gonzalez-Zulueta, D. Esrig, N. Miyao, Y.C. Tsai, S.P. Lerner, C. Schmutte, A.S. Yang and R. Cote et al., 1994. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788.
23. UICC, 1978. TNM Classification of Malignant Tumors. 3rd Edn., Springer-Verlag, Geneva, Switzerland.
24. van Dekken, H., J.G. Pizzolo, V.E. Reuter and M.R. Melamed, 1990. Cytogenctic analysis of human solid tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes. Cytogenet Cell Genet., 54: 103-137.
25. Waldman, F.M., P.R. Carroll, R. Kerschmann, M.B. Cohen, F.G. Field and B.H. Mayall, 1991. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51: 3807-3813.
26. Warren, W., P.J. Biggs, M. El-Baz, M.A. Ghoneim, MR. Stratton and S. Venitt, 1995. Mutations of the p53 gene in schistosomal bladder cancer: A study of 92 tumors from Egyptian patients and comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumors. Carcinogenesis, 16: 1181-1189.
27. World Health Organization, 1985. The control of schistosomiasis. Report of a WHO expert committee. Technical Report Series No. 728, WHO, Geneva, Switzerland.
28. World Health Organization, 1993. The control of schistosoiniasis. Report of a WHO expert committee. Public health impact of schistosomiasis: Disease and mortality. Bull. WHO, 71: 657-662.
29. Wu, R.-L., I. Osman, X.-R. Wu, M.-L. Lu, Z.-F. Zhang, F.-X. Liang, R. Hamza, H. Scher, C. Cordon-Cardo and T.-T. Sun, 1998. Uroplalkin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: Alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res., 58: 1291-1297.